Semaglutide vs Ozempic: Which GLP-1 Drug Is Better in 2025?
In the ring: Semaglutide and Ozempic—who takes the crown in 2025? Picture this: It’s 2025, and the battle for the best GLP-1 receptor agonist is fiercer than ever. Semaglutide, the newer kid on the block, has been making waves, but Ozempic remains a trusted veteran in the fight against weight and type 2 diabetes. As … Read more